Aerospace and defense company AXON (NASDAQ:AXON) will be reporting results tomorrow after market hours. Here’s what to expect. Axon beat analysts’ revenue expectations by 3.6% last quarter ...

Apnimed, Inc., a pharmaceutical company focused on discovering, developing, and commercializing first-in-class oral therapies for the neuromuscular dysfunction associated with obstructive sleep apnea ...

CAMBRIDGE, Mass., March 11, 2025 /PRNewswire/ -- Apnimed, Inc., a pharmaceutical company focused on discovering, developing, and commercializing first-in-class oral therapies for the neuromuscular ...

Shares of aerospace and defense company AXON (NASDAQ:AXON) jumped 18.3% in the morning session after the company reported strong fourth-quarter results that blew past analysts' revenue ...

AXON was trading ~10% down Wednesday afternoon at $640.15. "Shares are up 20% year-to-date and trading at valuations that are lofty, by any metric," said the research note.

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars ...

Axon Enterprise is a market leader in public safety technologies, with products ranging from Taser devices to body cameras and cloud solutions for law enforcement agencies. In recent years ...

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge. Explore Axon Enterprise stock price, quotes, charts and forecasts with Benzinga. Stay updated on market ...